Dexelance SpA
MIL:DEX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.46
9.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DEX stock under the Base Case scenario is 9.65 EUR. Compared to the current market price of 5.46 EUR, Dexelance SpA is Undervalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Dexelance SpA.
| US |
|
Tempur Sealy International Inc
NYSE:TPX
|
|
| US |
|
Mohawk Industries Inc
NYSE:MHK
|
|
| CN |
|
Oppein Home Group Inc
SSE:603833
|
|
| TW |
|
Nien Made Enterprise Co Ltd
TWSE:8464
|
|
| CN |
|
Jason Furniture Hangzhou Co Ltd
SSE:603816
|
|
| CN |
H
|
HHC Changzhou Corp
SZSE:301061
|
|
| HK |
|
Man Wah Holdings Ltd
HKEX:1999
|
|
| CN |
|
Suofeiya Home Collection Co Ltd
SZSE:002572
|
|
| US |
|
La-Z-Boy Inc
NYSE:LZB
|
|
| CN |
D
|
De Rucci Healthy Sleep Co Ltd
SZSE:001323
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Dexelance SpA
Balance Sheet Decomposition
Dexelance SpA
| Current Assets | 138.3m |
| Cash & Short-Term Investments | 32.1m |
| Receivables | 59.9m |
| Other Current Assets | 46.3m |
| Non-Current Assets | 292.3m |
| Long-Term Investments | 1.5m |
| PP&E | 62.7m |
| Intangibles | 220.6m |
| Other Non-Current Assets | 7.4m |
| Current Liabilities | 130.7m |
| Accounts Payable | 47.1m |
| Accrued Liabilities | 11.6m |
| Other Current Liabilities | 72m |
| Non-Current Liabilities | 138.3m |
| Long-Term Debt | 55.6m |
| Other Non-Current Liabilities | 82.7m |
Free Cash Flow Analysis
Dexelance SpA
| EUR | |
| Free Cash Flow | EUR |
Earnings Waterfall
Dexelance SpA
|
Revenue
|
481.1m
EUR
|
|
Cost of Revenue
|
-299.2m
EUR
|
|
Gross Profit
|
181.9m
EUR
|
|
Operating Expenses
|
-167.6m
EUR
|
|
Operating Income
|
14.3m
EUR
|
|
Other Expenses
|
-4.9m
EUR
|
|
Net Income
|
9.5m
EUR
|
DEX Profitability Score
Profitability Due Diligence
Dexelance SpA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Dexelance SpA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
DEX Solvency Score
Solvency Due Diligence
Dexelance SpA's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Dexelance SpA's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DEX Price Targets Summary
Dexelance SpA
According to Wall Street analysts, the average 1-year price target for DEX is 9.35 EUR with a low forecast of 6.77 EUR and a high forecast of 13.44 EUR.
Dividends
Current shareholder yield for DEX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one DEX stock under the Base Case scenario is 9.65 EUR.
Compared to the current market price of 5.46 EUR, Dexelance SpA is Undervalued by 43%.